Some study participants may not be able to come to hospitals, clinics, or other study locations because of infection, self-isolation, travel restrictions, facilities restrictions, being in a COVID-19 high risk group, or the temporary halt to some in-person human subjects research. Study teams should submit a Modification for any alternatives. These might include (but are not limited to):
- Phone calls, including use of telemedicine options.
- Use of digital technology to record symptoms (e.g., cell phone photo of a healing surgical wound).
- Visits from appropriately screened and trained study staff, visiting nurses, home health aids, etc., to conduct study procedures.
- Providing study medications through an appropriate home delivery mechanism. You should first consult with the entity providing the medication (e.g., UW Pharmacy or Investigational Drug Services; study sponsor) to find out about applicable state and federal laws.